[Analysis of proteomic spectra in serum from patients with laryngeal carcinoma by SELDI-TOF-MS technology]. |
20359086 |
Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi |
[Rabies vaccination with regards to its epidemiology (author's transl)]. |
1237467 |
Immun Infekt |
Altered expression and localization of creatine kinase B, heterogeneous nuclear ribonucleoprotein F, and high mobility group box 1 protein in the nuclear matrix associated with colon cancer. |
16424007 |
Cancer Res |
Assessing the statistical significance of the achieved classification error of classifiers constructed using serum peptide profiles, and a prescription for random sampling repeated studies for massive high-throughput genomic and proteomic studies. |
19305632 |
Cancer Inform |
Association of polymorphisms in the cyclin D1 and XPD genes and susceptibility to cancers of the upper aero-digestive tract. |
15754315 |
Mol Carcinog |
Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer. |
12844488 |
Carcinogenesis |
Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma. |
17409457 |
Cancer Res |
Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. |
14718398 |
Clin Chem |
Colon cancer specific nuclear matrix protein alterations in human colonic adenomatous polyps. |
14743395 |
J Cell Biochem |
Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer. |
17909350 |
J Thorac Oncol |
Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling. |
17220337 |
Cancer Epidemiol Biomarkers Prev |
Early identification of individuals with prostate cancer in negative biopsies. |
15017188 |
J Urol |
Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility. |
15613711 |
Clin Chem |
Feature Selection for Classification of SELDI-TOF-MS Proteomic Profiles. |
16309341 |
Appl Bioinformatics |
Frequent expression of Niban in head and neck squamous cell carcinoma and squamous dysplasia. |
19536772 |
Head Neck |
Gastrin-releasing peptide receptor-mediated autocrine growth in squamous cell carcinoma of the head and neck. |
11880476 |
J Natl Cancer Inst |
Identification of calreticulin as a nuclear matrix protein associated with human colon cancer. |
12704787 |
J Cell Biochem |
Identification of nuclear matrix protein alterations associated with human colon cancer. |
11956108 |
Cancer Res |
Initial analyses of colon cancer-specific antigen (CCSA)-3 and CCSA-4 as colorectal cancer-associated serum markers. |
17575123 |
Cancer Res |
Intersession reproducibility of mass spectrometry profiles and its effect on accuracy of multivariate classification models. |
17766268 |
Bioinformatics |
Mitogenic effects of gastrin-releasing peptide in head and neck squamous cancer cells are mediated by activation of the epidermal growth factor receptor. |
13679857 |
Oncogene |
Multianalyte profiling of serum cytokines for detection of pancreatic cancer. |
17192050 |
Cancer Biomark |
Multiple cytokine and growth factor serum biomarkers predict therapeutic response and survival in advanced-stage head and neck cancer patients. |
17545511 |
Clin Cancer Res |
Multiplexed analysis of serum cytokines as biomarkers in squamous cell carcinoma of the head and neck patients. |
15744170 |
Laryngoscope |
No association between the XPD 312, 751, or XRCC1 399 polymorphisms and K-ras gene mutation in smoking non-small-cell lung cancer. |
15066937 |
Cancer Epidemiol Biomarkers Prev |
SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer. |
18024530 |
Clin Chem |
Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancer. |
15258333 |
Dis Markers |
SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells. |
15342401 |
Cancer Res |